€
0. 53
-0.01
-1.8519%
€
44.32M Market Cap
- P/E Ratio
- Div Yield
653 Volume
- Eps
€ 0.54
Previous Close Want to track 3NQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nano mRNA Co., Ltd. (3NQ) Statistics
Valuation metrics
Market Cap 44.32M
Enterprise value -17.59M
Trailing P/E (ttm) -0.05
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.26
Price/Book (mrq) 2.21
Enterprise Value/Revenue -18.77
Enterprise Value/EBITDA 0.03
Overview
Shares outstanding 71.95M
Float 70.91M
Shares short -
% Held by insiders 0.08%
% Held by institutions 0%
Average volume (10 days) 65
Average volume (90 days) 364
Price summary
52-Week low 0.52
52-Week high 1.15
Beta 0.36
50-Day moving average 0.73
200-Day moving average 0.79
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 100:1
Last split Date 27 Mar 2014
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.72%
Operating margin -8.25%
Operational effectiveness
Return on assets -0.12%
Return on equity -0.3%
Income Statement
Revenue (ttm) 937.42K
Revenue per share (ttm) 2.38
Quarterly revenue growth (yoy) 0.76%
Gross profit (ttm) 824.29K
EBITDA -
Net income to common (ttm) -5.08M
Diluted EPS (ttm) -0.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 26.45M
Total cash per share (mrq) 62.82
Total debt (mrq) 8.62M
Total Debt/Equity (mrq) 44.89
Current ratio (mrq) 5.29%
Book value per share (mrq) 0.25
Cash Flow
Cash flow statement -4.4M
Levered free cash flow (LFCF) -4.24M
